Inibitori del cotrasportatore sodio-glucosio di tipo 2 in pazienti sottoposti a trapianto renale
Several recent randomized controlled trials (RCTs) have demonstrated the broad clinical application of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in improving kidney and cardiovascular outcomes in patients with native kidney disease. In January 2023, Dapagliflozin became the first SGLT2 inh...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Italian |
| Published: |
AboutScience Srl
2023-11-01
|
| Series: | Giornale di Clinica Nefrologia e Dialisi |
| Subjects: | |
| Online Access: | https://journals.aboutscience.eu/index.php/gcnd/article/view/2620 |